LYVE1 and B-cell chronic lymphocytic leukemia: Next, using IF staining of the dura mater with anti–LYVE-1, image quantification of different regions of interest at the hotspot areas along the TS indicated that LYVE-1 density was significantly reduced in the hotspots and COS area of CLL-treated mice compared with PBSL controls (Figure 2B).